Cirrus Logic Inc. (CRUS) is Trading Lower on Unusual Volume for January 05

Equities Staff |

Cirrus Logic Inc. (CRUS) experienced unusually high volume on Jan. 05, as the stock lost 5.89% to a closing price of $27.58. The stock saw 2.9 million shares trade hands over the course of the day on 19,532 trades. Given that the stock’s average daily volume over the last month has been 1.73 million shares a day, this represents a pretty substantial spike over the norm.

Cirrus Logic Inc. has a P/B ratio of 2.12. It also has a P/E ratio of 17.1. The stock has traded between $38.20 and $22.63 over the last 52-weeks, its 50-day SMA is now $31.28, and its 200-day SMA $32.32.

Cirrus Logic Inc develops high-precision, analog and mixed-signal integrated circuits (ICs) for a range of audio and energy markets.Its main product line includes audio products and energy products.

Headquartered in Austin, TX, Cirrus Logic Inc. has 1,104 employees and is currently under the leadership of CEO Jason P. Rhode.

For a complete fundamental analysis analysis of Cirrus Logic Inc., check out’s Stock Valuation Analysis report for CRUS. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.